Logo image of IKT

INHIBIKASE THERAPEUTICS INC (IKT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IKT - US45719W2052 - Common Stock

1.685 USD
-0.05 (-3.16%)
Last: 1/26/2026, 11:02:08 AM
Fundamental Rating

3

Overall IKT gets a fundamental rating of 3 out of 10. We evaluated IKT against 525 industry peers in the Biotechnology industry. While IKT has a great health rating, there are worries on its profitability. IKT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IKT has reported negative net income.
  • IKT had a negative operating cash flow in the past year.
  • IKT had negative earnings in each of the past 5 years.
  • In the past 5 years IKT always reported negative operating cash flow.
IKT Yearly Net Income VS EBIT VS OCF VS FCFIKT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M -25M

1.2 Ratios

  • IKT has a Return On Assets of -59.87%. This is comparable to the rest of the industry: IKT outperforms 43.05% of its industry peers.
  • IKT's Return On Equity of -65.37% is in line compared to the rest of the industry. IKT outperforms 58.86% of its industry peers.
Industry RankSector Rank
ROA -59.87%
ROE -65.37%
ROIC N/A
ROA(3y)-77.15%
ROA(5y)-57.11%
ROE(3y)-96.05%
ROE(5y)-71.15%
ROIC(3y)N/A
ROIC(5y)N/A
IKT Yearly ROA, ROE, ROICIKT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IKT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IKT Yearly Profit, Operating, Gross MarginsIKT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

8

2. Health

2.1 Basic Checks

  • IKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IKT has more shares outstanding
  • Compared to 5 years ago, IKT has more shares outstanding
  • There is no outstanding debt for IKT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IKT Yearly Shares OutstandingIKT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IKT Yearly Total Debt VS Total AssetsIKT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 15.53 indicates that IKT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 15.53, IKT belongs to the best of the industry, outperforming 86.29% of the companies in the same industry.
  • IKT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.53
ROIC/WACCN/A
WACC8.88%
IKT Yearly LT Debt VS Equity VS FCFIKT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 11.73 indicates that IKT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 11.73, IKT belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
  • A Quick Ratio of 11.73 indicates that IKT has no problem at all paying its short term obligations.
  • IKT has a Quick ratio of 11.73. This is amongst the best in the industry. IKT outperforms 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 11.73
Quick Ratio 11.73
IKT Yearly Current Assets VS Current LiabilitesIKT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.04% over the past year.
  • The Revenue for IKT has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)66.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, IKT will show a very strong growth in Earnings Per Share. The EPS will grow by 21.17% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y79.52%
EPS Next 2Y33.32%
EPS Next 3Y21.17%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IKT Yearly Revenue VS EstimatesIKT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2026 2027 1M 2M 3M 4M
IKT Yearly EPS VS EstimatesIKT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

1

4. Valuation

4.1 Price/Earnings Ratio

  • IKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IKT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IKT Price Earnings VS Forward Price EarningsIKT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IKT Per share dataIKT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IKT's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.32%
EPS Next 3Y21.17%

0

5. Dividend

5.1 Amount

  • No dividends for IKT!.
Industry RankSector Rank
Dividend Yield 0%

INHIBIKASE THERAPEUTICS INC / IKT FAQ

What is the ChartMill fundamental rating of INHIBIKASE THERAPEUTICS INC (IKT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IKT.


Can you provide the valuation status for INHIBIKASE THERAPEUTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to INHIBIKASE THERAPEUTICS INC (IKT). This can be considered as Overvalued.


What is the profitability of IKT stock?

INHIBIKASE THERAPEUTICS INC (IKT) has a profitability rating of 1 / 10.


Can you provide the financial health for IKT stock?

The financial health rating of INHIBIKASE THERAPEUTICS INC (IKT) is 8 / 10.